Financial conflicts of interest of physicians followed by oncology journals on Twitter

被引:0
作者
Betts, Colton [1 ]
Kakkilaya, Akash [1 ]
Vasireddy, Satvik [2 ]
Arora, Neha [1 ]
Prasad, Vinay [3 ]
Powell, Kerrington [1 ]
机构
[1] Texas A&M Hlth Sci Ctr, Sch Med, 8447 Riverside Pkwy, Bryan, TX 77807 USA
[2] Touro Univ Nevada, Coll Osteopath Med, 874 Amer Pacific Dr, Henderson, NV 89014 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
关键词
Oncology; Twitter; Social media; Financial conflict of interest; Health policy; Industry; INDUSTRY;
D O I
10.1007/s00432-023-05230-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Physicians have increasingly adopted Twitter as a discussion and distribution platform for oncology research. While the influence of financial conflicts of interests (FCOI) on medical research is well documented, their role in the dissemination of research on social media platforms is not well known. In this study, we sought to evaluate the FCOIs of physicians followed by the top three oncology journals on Twitter.Materials and Methods We used the Open Payments Search Tool (https://openpaymentsdata.cms.gov) to assess FCOIs between 2016 and 2021 of United States (US) physicians followed by three oncology journals (Journal of Clinical Oncology, The Lancet Oncology, and Annals of Oncology) on Twitter.Results Of 1914 Twitter accounts followed by the top three oncology journals on Twitter, 547 (28.6%) belonged to US physicians. Of these, 463 (84.6%) received general payments between 2016 and 2021. After excluding 30 US physicians currently in residency or fellowship, this percentage increased to 88.2% (n = 456/517). Combined, the median (interquartile range) general payment amount was $8100 ($200-90,000). Additionally, over $42 million in general payments were made between 2016 and 2021.Conclusion Our findings offer insight on FCOIs between oncology journals and US physicians on Twitter. These findings may serve as the foundation for future research regarding optimal medical journal conduct on social media platforms.
引用
收藏
页码:14137 / 14144
页数:8
相关论文
共 17 条
  • [11] Social Medicine: Twitter in Healthcare
    Pershad, Yash
    Hangge, Patrick T.
    Albadawi, Hassan
    Oklu, Rahmi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2018, 7 (06):
  • [12] Financial conflicts of interest of physicians followed by neurosurgical journals on Twitter
    Powell, Kerrington
    McCall, Kyle
    Hooda, Karan
    Prasad, Vinay
    Kakkilaya, Akash
    [J]. INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2023, 38 (03) : 679 - 686
  • [13] Financial conflicts of interest of OncoAlert: An informal oncology professional network
    Powell, Kerrington
    Kakkilaya, Akash
    Haslam, Alyson
    Prasad, Vinay
    [J]. JOURNAL OF CANCER POLICY, 2022, 34
  • [14] Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward
    Prasad, V.
    Rajkumar, S. V.
    [J]. BLOOD CANCER JOURNAL, 2016, 6 : e489 - e489
  • [15] Financial Conflicts of Interest Among Hematologist-Oncologists on Twitter
    Tao, Derrick L.
    Boothby, Aaron
    McLouth, Joel
    Prasad, Vinay
    [J]. JAMA INTERNAL MEDICINE, 2017, 177 (03) : 425 - 427
  • [16] Author Financial Conflicts of Interest, Industry Funding, and Clinical Practice Guidelines for Anticancer Drugs
    Tibau, Ariadna
    Bedard, Philippe L.
    Srikanthan, Amirrtha
    Ethier, Josee-Lyne
    Vera-Badillo, Francisco E.
    Templeton, Arnoud J.
    Ocana, Alberto
    Seruga, Bostjan
    Barnadas, Agusti
    Amir, Eitan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) : 100 - U158
  • [17] Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform
    Torgerson, Trevor
    Wayant, Cole
    Cosgrove, Lisa
    Akl, Elie A.
    Checketts, Jake
    Dal Re, Rafael
    Gill, Jennifer
    Grover, Samir C.
    Khan, Nasim
    Khan, Rishad
    Marusic, Ana
    McCoy, Matthew S.
    Mitchell, Aaron
    Prasad, Vinay
    Vassar, Matt
    [J]. BMJ EVIDENCE-BASED MEDICINE, 2022, 27 (01) : 46 - 54